These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 12136741)

  • 1. Prescribing of gastroprotective drugs among elderly NSAID users in The Netherlands.
    van Dijk KN; ter Huurne K; de Vries CS; van den Berg PB; Brouwers JR; de Jong-van den Berg LT
    Pharm World Sci; 2002 Jun; 24(3):100-3. PubMed ID: 12136741
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Concomitant use of gastroprotective drugs among elderly NSAID/COX-2 selective inhibitor users: a nationwide register-based study.
    Johnell K; Fastbom J
    Clin Drug Investig; 2008; 28(11):687-95. PubMed ID: 18840011
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The risk of upper gastrointestinal bleeding in elderly users of aspirin and other non-steroidal anti-inflammatory drugs: the role of gastroprotective drugs.
    Pilotto A; Franceschi M; Leandro G; Paris F; Niro V; Longo MG; D'Ambrosio LP; Andriulli A; Di Mario F
    Aging Clin Exp Res; 2003 Dec; 15(6):494-9. PubMed ID: 14959953
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High concomitant use of interacting drugs and low use of gastroprotective drugs among NSAID users in an unselected elderly population: a nationwide register-based study.
    Ljung R; Lu Y; Lagergren J
    Drugs Aging; 2011 Jun; 28(6):469-76. PubMed ID: 21639406
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quality of Co-Prescribing NSAID and Gastroprotective Medications for Elders in The Netherlands and Its Association with the Electronic Medical Record.
    Opondo D; Visscher S; Eslami S; Verheij RA; Korevaar JC; Abu-Hanna A
    PLoS One; 2015; 10(6):e0129515. PubMed ID: 26110650
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Frequent prescribing of drugs with potential gastrointestinal toxicity among continuous users of non-steroidal anti-inflammatory drugs.
    Helin-Salmivaara A; Huupponen R; Virtanen A; Lammela J; Klaukka T
    Eur J Clin Pharmacol; 2005 Jul; 61(5-6):425-31. PubMed ID: 15952021
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Underutilization of preventive strategies in patients receiving NSAIDs.
    Sturkenboom MC; Burke TA; Dieleman JP; Tangelder MJ; Lee F; Goldstein JL
    Rheumatology (Oxford); 2003 Nov; 42 Suppl 3():iii23-31. PubMed ID: 14585915
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Time-trends in the prescribing of gastroprotective agents to primary care patients initiating low-dose aspirin or non-steroidal anti-inflammatory drugs: a population-based cohort study.
    Warlé-van Herwaarden MF; Koffeman AR; Valkhoff VE; 't Jong GW; Kramers C; Sturkenboom MC; De Smet PA
    Br J Clin Pharmacol; 2015 Sep; 80(3):589-98. PubMed ID: 25777983
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Co-prescription of gastroprotective agents and their efficacy in elderly patients taking nonsteroidal anti-inflammatory drugs: a systematic review of observational studies.
    Medlock S; Eslami S; Askari M; Taherzadeh Z; Opondo D; de Rooij SE; Abu-Hanna A
    Clin Gastroenterol Hepatol; 2013 Oct; 11(10):1259-1269.e10. PubMed ID: 23792548
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of nonsteroidal anti-inflammatory drugs and gastroprotective agents before the advent of cyclooxygenase-2-selective inhibitors: analysis of a large United States claims database.
    Schnitzer TJ; Kong SX; Mavros PP; Straus WL; Watson DJ
    Clin Ther; 2001 Dec; 23(12):1984-98. PubMed ID: 11813933
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prescription of nonselective NSAIDs, coxibs and gastroprotective agents in the era of rofecoxib withdrawal - a 617,400-patient study.
    Valkhoff VE; van Soest EM; Masclee GM; de Bie S; Mazzaglia G; Molokhia M; Kuipers EJ; Sturkenboom MC
    Aliment Pharmacol Ther; 2012 Oct; 36(8):790-9. PubMed ID: 22928490
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Concomitant use of SSRIs, NSAIDs/aspirin and gastroprotective drugs among residents of long-term care facilities: a medical record review.
    Bell JS; Taipale HT; Soini H; Pitkälä KH
    Clin Drug Investig; 2011; 31(5):337-44. PubMed ID: 21366362
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effectiveness of interventions by community pharmacists to reduce risk of gastrointestinal side effects in nonselective nonsteroidal anti-inflammatory drug users.
    Teichert M; Griens F; Buijs E; Wensing M; De Smet PA
    Pharmacoepidemiol Drug Saf; 2014 Apr; 23(4):382-9. PubMed ID: 24535837
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Non-steroidal anti-inflammatory and cytoprotective drug co-prescription in general practice. A general practitioner-based survey in France.
    Clinard F; Bardou M; Sgro C; Lefevre N; Raphael F; Paille F; Dumas M; Hillon P; Bonithon-Kopp C
    Eur J Clin Pharmacol; 2001 Dec; 57(10):737-43. PubMed ID: 11829204
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of gastroprotective agents in recommended doses in hospitalized patients receiving NSAIDs: a drug utilization study.
    Erdeljic V; Francetic I; Macolic Sarinic V; Bilusic M; Makar Ausperger K; Huic M; Mercep I
    Pharm World Sci; 2006 Oct; 28(5):318-25. PubMed ID: 17111239
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The use of prophylactic gastroprotective therapy in patients with nonsteroidal anti-inflammatory drug- and aspirin-associated ulcer bleeding: a cross-sectional study.
    Ho CW; Tse YK; Wu B; Mulder CJ; Chan FK
    Aliment Pharmacol Ther; 2013 Apr; 37(8):819-24. PubMed ID: 23432193
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A regional audit of the use of COX-2 selective non-steroidal anti-inflammatory drugs (NSAIDs) in rheumatology clinics in the West Midlands, in relation to NICE guidelines.
    Price-Forbes AN; Callaghan R; Allen ME; Rowe IF
    Rheumatology (Oxford); 2005 Jul; 44(7):921-4. PubMed ID: 15827035
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prescription audit of NSAIDs and gastroprotective strategy in elderly in primary care.
    Al Khaja KAJ; Veeramuthu S; Isa HA; Sequeira RP
    Int J Risk Saf Med; 2017; 29(1-2):57-68. PubMed ID: 28885223
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gastroprotective therapy and risk of gastrointestinal ulcers: risk reduction by COX-2 therapy.
    Wolfe F; Anderson J; Burke TA; Arguelles LM; Pettitt D
    J Rheumatol; 2002 Mar; 29(3):467-73. PubMed ID: 11908558
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gastroprotective drugs in Australia: utilization patterns between 1997 and 2006 in relation to NSAID prescribing.
    Barozzi N; Tett SE
    Clin Ther; 2009 Apr; 31(4):849-61. PubMed ID: 19446158
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.